Home
Mailbox
Boards
Favorites
Whats Hot!
Login - Join Now!
Search
Search Type
Board
Post
Member
WINNERS CIRCLE
(Total Views: 73)
Posted On: 07/21/2025 2:06:41 PM
Post#
of 29851
Posted By:
Depcom
$CUE
– Cue Biopharma Inc.
Took a position at .90
Due Diligence: Immunotherapy company targeting cancer and autoimmune diseases.
Why It Should Run: Recent insider buying and strong preclinical data.
Target Price: $1.20
(0)
(0)
Newer
Older